Live Breaking News & Updates on Japan Takeda Pharmaceutical Co

Stay updated with breaking news from Japan takeda pharmaceutical co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Wipro lost its CFO to Cognizant. Then it lost a big client

Wipro had signed the Japanese client Takeda Pharmaceuticals 10 years ago ....

New Jersey , United States , Mohd Haque , Surya Gummadi , Phil Fersht , Thierry Delaporte , Ceos Ravi Kumar , Ravi Kumar , Jatin Dalal , Japan Takeda Pharmaceutical Co , Nasdaq Listed Cognizant , Takeda Pharmaceutical , Cognizant Americas , Jersey Headquartered Cognizant , Takeda Pharma , It Sector , Information Technology ,

Novartis Sells Eye Drugs to Bausch for Up to $2.5B

The deal includes Xiidra, a prescription medicine for dry eye disease, that generated $487 million in sales last year. ....

Japan Takeda Pharmaceutical Co , Lomb Corp , Chief Executive Officer Vas Narasimhan , Takeda Pharmaceutical , Basel Based Novartis , Wall Street Journal ,

AI-made drug starts human trials

We've curated insightful analysis on how generative AI is being used to make drugs more efficiently than traditional methods. ....

Alex Zhavoronkov , Lovisa Afzelius , Japan Takeda Pharmaceutical Co , Insilico Medicine , Takeda Pharmaceutical , Apriori Bio ,

Takeda: HYQVIA Gets FDA Approval To Treat Primary Immunodeficiency In Children

Japan's Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Tuesday that the U.S. Food and Drug Administration has approved a supplemental biologics license application or sBLA to expand the use of HYQVIA to treat primary immunodeficiency or PI in children 2-16 years old. ....

More Such Health News , Japan Takeda Pharmaceutical Co , Drug Administration , Takeda Pharmaceutical , Derived Therapies Business Unit , Fda Approval , Primary Immunodeficiency , Takeda Hyqvia ,